|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5573924A
(en)
|
1992-09-08 |
1996-11-12 |
Immunex Corporation |
CD27 ligand
|
|
DE19747418C1
(de)
|
1997-10-27 |
1999-07-15 |
Deutsches Krebsforsch |
Inhibitor-Protein des wnt-Signalwegs
|
|
US6500633B1
(en)
|
2000-04-26 |
2002-12-31 |
Atairgin Technologies, Inc. |
Method of detecting carcinomas
|
|
US20030148321A1
(en)
|
2001-08-24 |
2003-08-07 |
Iris Pecker |
Methods and kits for diagnosing and monitoring hematopoietic cancers
|
|
EP1470247A2
(en)
|
2001-11-05 |
2004-10-27 |
Deutsches Krebsforschungszentrum |
Novel genetic markers for leukemias
|
|
ES2394018T3
(es)
|
2001-11-27 |
2013-01-15 |
Ucb Pharma S.A. |
Procedimientos para el diagnóstico y el tratamiento de cánceres derivados de células epiteliales
|
|
US7261892B2
(en)
|
2001-11-27 |
2007-08-28 |
Celltech R&D Limited |
Methods for diagnosis and treatment of epithelial-derived cancers
|
|
US8404716B2
(en)
|
2002-10-15 |
2013-03-26 |
Celgene Corporation |
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
|
|
US8039218B2
(en)
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
|
JP5356648B2
(ja)
|
2003-02-20 |
2013-12-04 |
シアトル ジェネティックス， インコーポレイテッド |
抗ｃｄ７０抗体−医薬結合体、ならびに癌および免疫障害の処置のためのそれらの使用
|
|
US20080025989A1
(en)
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
CA2569509C
(en)
|
2004-06-03 |
2014-08-12 |
Novimmune S.A. |
Anti-cd3 antibodies and methods of use thereof
|
|
WO2006044643A2
(en)
|
2004-10-15 |
2006-04-27 |
Seattle Genetics, Inc. |
Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US8337838B2
(en)
|
2004-10-15 |
2012-12-25 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US7641903B2
(en)
|
2004-10-15 |
2010-01-05 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
JP5122441B2
(ja)
|
2005-04-19 |
2013-01-16 |
シアトル ジェネティックス， インコーポレイテッド |
ヒト化抗ｃｄ７０結合剤およびその使用
|
|
EP1872124A4
(en)
|
2005-04-19 |
2008-06-11 |
Prediction Sciences Llc |
DIAGNOSIS MARKET FOR BREAST CANCER TREATMENT AND PROGRESSION AND METHOD OF USE THEREOF
|
|
WO2007011856A2
(en)
|
2005-07-15 |
2007-01-25 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for differential diagnosis of chronic lymphocytic leukemia
|
|
NZ566395A
(en)
|
2005-09-26 |
2012-03-30 |
Medarex Inc |
Human monoclonal antibodies to CD70
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
NZ573646A
(en)
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
|
EP2055400A1
(en)
|
2006-07-24 |
2009-05-06 |
Senda Kensetsu Kabushiki Kaisha |
Method of descaling metal wire rod and apparatus therefor
|
|
PT2099823E
(pt)
|
2006-12-01 |
2014-12-22 |
Seattle Genetics Inc |
Agentes de ligação ao alvo variantes e suas utilizações
|
|
MX2009006277A
(es)
|
2006-12-14 |
2009-07-24 |
Medarex Inc |
Anticuerpos humanos que se enlazan a cd70 y usos de los mismos.
|
|
KR100807069B1
(ko)
|
2007-09-21 |
2008-02-25 |
고려대학교 산학협력단 |
암 치료용 의약 조성물
|
|
US20100267626A1
(en)
|
2007-11-05 |
2010-10-21 |
Novartis Ag |
Methods and compositions for measuring wnt activation and for treating wnt-related cancers
|
|
GB2461546B
(en)
|
2008-07-02 |
2010-07-07 |
Argen X Bv |
Antigen binding polypeptides
|
|
WO2010014948A1
(en)
|
2008-08-01 |
2010-02-04 |
The University Of Utah Research Foundation |
Methods of treatment using wnt inhibitors
|
|
WO2010019921A2
(en)
|
2008-08-15 |
2010-02-18 |
The Regents Of The University Of California |
Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia
|
|
SG190568A1
(en)
|
2008-09-26 |
2013-06-28 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
JP5748653B2
(ja)
|
2009-04-10 |
2015-07-15 |
協和発酵キリン株式会社 |
抗ｔｉｍ−３抗体を用いた血液腫瘍治療法
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
CN105037355B
(zh)
|
2009-08-10 |
2017-06-06 |
萨穆梅德有限公司 |
Wnt信号传导途径的吲唑抑制剂及其治疗用途
|
|
US20120178111A1
(en)
|
2009-09-23 |
2012-07-12 |
Diamandis Eleftherios P |
Methods and compositions for the detection of lung cancers
|
|
KR101773216B1
(ko)
|
2009-12-29 |
2017-08-31 |
교와 핫꼬 기린 가부시키가이샤 |
항 ｃｄ27 항체
|
|
AU2011262758B8
(en)
|
2010-06-11 |
2014-09-04 |
Kyowa Kirin Co., Ltd. |
Anti-tim-3 antibody
|
|
PT2643322T
(pt)
|
2010-11-23 |
2017-11-13 |
Abbvie Inc |
Sais e formas cristalinas de um agente indutor de apoptose
|
|
US9403906B2
(en)
|
2011-01-19 |
2016-08-02 |
Cantargia Ab |
Method of treatment of a solid tumor with interleukin-1 accessory protein antibody
|
|
EP2686347B1
(en)
|
2011-03-16 |
2018-05-02 |
argenx BVBA |
Antibodies to cd70
|
|
WO2013006490A2
(en)
|
2011-07-01 |
2013-01-10 |
Cellerant Therapeutics, Inc. |
Antibodies that specifically bind to tim3
|
|
MX353958B
(es)
|
2011-09-22 |
2018-02-07 |
Amgen Inc |
Proteinas de union al antigeno cd27l.
|
|
WO2013093508A2
(en)
|
2011-12-22 |
2013-06-27 |
Oslo University Hospital Hf |
Wnt pathway inhibitors
|
|
NZ629697A
(en)
|
2012-03-15 |
2017-01-27 |
Janssen Biotech Inc |
Human anti-cd27 antibodies, methods and uses
|
|
KR20140145148A
(ko)
|
2012-03-21 |
2014-12-22 |
에리테끄 파르마 |
급성 골수성 백혈병 치료를 위한 약제
|
|
US9801851B2
(en)
|
2012-05-23 |
2017-10-31 |
St. Jude Children's Research Hospital |
Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias
|
|
EP2861590B1
(en)
|
2012-06-15 |
2017-10-25 |
Curegenix Inc. |
Compound as wnt signaling inhibitor, composition, and use thereof
|
|
WO2014045101A1
(en)
|
2012-09-21 |
2014-03-27 |
Cellzome Gmbh |
Tetrazolo quinoxaline derivatives as tankyrase inhibitors
|
|
WO2014100772A1
(en)
|
2012-12-21 |
2014-06-26 |
Cellerant Therapeutics, Inc. |
Antibodies that bind membrane-bound il1rap
|
|
LT2956173T
(lt)
|
2013-02-14 |
2017-06-26 |
Bristol-Myers Squibb Company |
Tubulizino junginiai, gavimo ir panaudojimo būdai
|
|
HUE045065T2
(hu)
|
2014-01-31 |
2019-12-30 |
Novartis Ag |
TIM-3 antitest molekulák és felhasználásaik
|
|
CN106456749B
(zh)
|
2014-03-11 |
2021-03-30 |
小利兰·斯坦福大学托管委员会 |
抗SIRPα抗体和双特异性巨噬细胞增强型抗体
|
|
WO2016111947A2
(en)
|
2015-01-05 |
2016-07-14 |
Jounce Therapeutics, Inc. |
Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究（慕尼黑）公司 |
Ｃｄ７０及ｃｄ３抗體構築體
|
|
US20180244792A1
(en)
|
2015-09-10 |
2018-08-30 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Anti-fibrotic effect of cd70
|
|
PE20181326A1
(es)
|
2015-11-03 |
2018-08-20 |
Janssen Biotech Inc |
Anticuerpos que se unen especificamente a pd-1 y sus usos
|
|
KR102124715B1
(ko)
*
|
2015-11-03 |
2020-06-18 |
제넨테크, 인크. |
암의 치료를 위한 bcl-2 억제제 및 mek 억제제의 조합물
|
|
EP3426655A1
(en)
|
2016-03-10 |
2019-01-16 |
Assia Chemical Industries Ltd. |
Solid state forms of venetoclax and processes for preparation of venetoclax
|
|
WO2017160954A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
RU2018146513A
(ru)
|
2016-06-09 |
2020-07-09 |
Др. Редди'С Лабораторис Лимитед |
Твердые формы венетоклакса и способы получения венетоклакса
|
|
EP3481397A1
(en)
|
2016-07-06 |
2019-05-15 |
Concert Pharmaceuticals Inc. |
Deuterated venetoclax
|
|
CN107648185A
(zh)
|
2016-07-25 |
2018-02-02 |
常州爱诺新睿医药技术有限公司 |
一种无定型Venetoclax与药用辅料的固体分散体及其制备方法
|
|
US20190177317A1
(en)
|
2016-08-12 |
2019-06-13 |
Mylan Laboratories Limited |
Process for the preparation of venetoclax
|
|
US10800777B2
(en)
|
2016-10-14 |
2020-10-13 |
Mylan Laboratories Limited |
Polymorphic forms of VENCLEXTA
|
|
EP3333167A1
(en)
|
2016-12-09 |
2018-06-13 |
LEK Pharmaceuticals d.d. |
Solid forms of venetoclax
|
|
CZ201769A3
(cs)
|
2017-02-06 |
2018-08-15 |
Zentiva, K.S. |
Pevné formy venetoclaxu
|
|
WO2018157803A1
(zh)
|
2017-02-28 |
2018-09-07 |
苏州科睿思制药有限公司 |
维奈妥拉的晶型及其制备方法
|
|
WO2018167652A1
(en)
|
2017-03-13 |
2018-09-20 |
Laurus Labs Limited |
Process for preparation of amorphous form of venetoclax
|
|
CN107089981A
(zh)
|
2017-04-24 |
2017-08-25 |
杭州科耀医药科技有限公司 |
一种BCL‑2抑制剂Venetoclax的合成方法
|
|
GB2567613A
(en)
*
|
2017-06-16 |
2019-04-24 |
Argenx Bvba |
Treatment for acute myeloid leukaemia
|
|
GB201800649D0
(en)
*
|
2018-01-16 |
2018-02-28 |
Argenx Bvba |
CD70 Combination Therapy
|
|
TWI848030B
(zh)
|
2018-12-18 |
2024-07-11 |
比利時商阿根思公司 |
Ｃｄ７０組合治療
|